Loading company…
New Jersey-based developer of an oral medication for abnormal involuntary movements caused by L-Dopa.
MentiNova is based in New Jersey, US, and is developing an oral medication to treat abnormal involuntary movements caused by L-Dopa, a treatment for Parkinson's disease. It is at the Seed stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in